Gwen Melincoff
Direttore/Membro del Consiglio presso GAIN THERAPEUTICS, INC.
Patrimonio netto: 2 M $ in data 30/04/2024
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Michael Heffernan | M | 59 | 22 anni | |
Anish Bhatnagar | M | 56 | 18 anni | |
Matthias Alder | M | 59 | 3 anni | |
Joseph Ciaffoni | M | 53 | 7 anni | |
Eyal Rubin | M | 48 | 5 anni | |
Shirley Kuhlmann | F | 40 | 6 anni | |
Gianluca Fuggetta | M | 35 | 2 anni | |
Dror Bashan | M | 57 | 5 anni | |
Ernest Mario | M | 85 | 17 anni | |
Yaron Naos | M | 60 | 20 anni | |
Dov Goldstein | M | 56 | 3 anni | |
Birgitte Volck | M | 61 | 5 anni | |
Matthew Pauls | M | 53 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 8 anni |
David B. Matias | M | - |
Vodia Capital LLC
Vodia Capital LLC Investment ManagersFinance Part of Robertson Stephens Wealth Management LLC, Vodia Capital LLC provides investment advisory services. The company is based in Concord, MA. The company was founded by David B. Matias. David B. Matias has been the CEO since incorporation. Vodia Capital was acquired by Robertson Stephens Wealth Management LLC on December 13, 2022. | - |
Donald E. Nickelson | M | 91 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 21 anni |
Shmuel Ben Zvi | M | 64 | 2 anni | |
Neil McFarlane | M | 51 | 2 anni | |
Andrew Sinclair | M | 52 | 6 anni | |
Scott Dreyer | M | 52 | 6 anni | |
Daniel Schneider | M | - | 6 anni | |
Rita Balice-Gordon | M | 63 | 4 anni | |
Manolo Bellotto | M | 53 | 6 anni | |
Scott Sudduth | M | - | 6 anni | |
Claude Nicaise | M | 71 | 3 anni | |
Claude H. Nash | M | - |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 24 anni |
Garen Bohlin | M | 76 | 9 anni | |
Pol Boudes | M | 67 | 5 anni | |
Eric Richman | M | 63 | 4 anni | |
Gino Santini | M | 66 | 12 anni | |
Bill Harris | M | 65 | 10 anni | |
Johanna Holldack | M | - | 7 anni | |
Hans-Peter Hasler | M | 68 | 3 anni | |
Jeffrey Riley | M | 61 | 5 anni | |
John Freund | M | 70 | 10 anni | |
Khalid Islam | M | 67 | 7 anni | |
John Fallon | M | 76 | 8 anni | |
Chaime Orlev | M | 53 | 7 anni | |
Aharon Schwartz | M | 80 | 10 anni | |
Amos Bar Shalev | M | 71 | 16 anni | |
Eliot Forster | M | 58 | 1 anni | |
Yael Hayon | M | 41 | 4 anni | |
Christopher James | M | - | 1 anni | |
Charles Horn | M | - | 2 anni | |
Maja Bergmann | F | - | 5 anni | |
Elena Cubero-Jorda | F | - | - | |
Fellous Yael | F | - | 2 anni | |
Kelly Clements | F | - | 2 anni | |
Neil M. Cowen | M | - | 7 anni | |
Colleen Tupper | F | 48 | 3 anni | |
Meredith S. Manning | F | - | - | |
Lauren Budesheim | F | - | - | |
Patricia Hirano | F | 58 | 7 anni | |
Thomas Smith | M | 63 | 2 anni | |
Arun Padmanabhan | M | - | 7 anni | |
James Mackaness | M | 60 | 5 anni | |
Kristen Yen | F | 55 | 18 anni | |
Geoffrey Coy | M | - | 5 anni | |
David P. Geoghegan | M | - |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 20 anni |
Gina Balderas | F | - | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Michael Dougherty | M | 66 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 11 anni |
Bruce Peacock | M | 72 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 3 anni |
Ambrose Bailey | M | 60 | - | |
Zeev Bronfeld | M | 71 | 17 anni | |
Matthew Gantz | M | 59 |
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International Inc. (BTG International) is a venture capital subsidiary of BTG Ltd founded in 1981. The firm is headquartered in West Conshohocken, Pennsylvania. | 7 anni |
Kjetil Hestdal | M | 64 | 21 anni | |
Yoseph Shaaltiel | M | 71 | 27 anni | |
Michael Metzger | M | 53 | - | |
Saadia Ozeri | M | 54 | 13 anni | |
Samuel Rubinstein | M | 59 | 2 anni | |
Raul Chertkoff | M | - | - | |
William Taylor | M | - | 7 anni | |
Anders Tuv | M | 46 | - | |
Robert Harrell | M | - |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 8 anni |
Jonathan R. Wolter | M | 73 | 2 anni | |
Ruth Wolfson | M | 77 | 14 anni | |
Alison B. Fleming | M | 49 | 19 anni | |
Howard Mayer | M | 62 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 6 anni |
Anne Hovi Worsøe | F | 60 | - | |
Synne Hermansen Røine | F | 45 | 6 anni | |
Jan Hendrik Egberts | M | 65 | 6 anni | |
Michael DeGeorge | M | - | 7 anni | |
Paul Brannelly | M | 51 | 6 anni | |
Gil Efron | M | 57 | 6 anni | |
George V. Hager | M | 68 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | - |
William Burns | M | 76 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 8 anni |
Charles Ballantyne | M | 64 | 1 anni | |
Avri Havron | M | 76 | 8 anni | |
Armando Anido | M | 66 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 8 anni |
Stuart J. M. Collinson | M | 64 | 3 anni | |
Eckard Weber | M | 73 | 1 anni | |
Patrick Heron | M | 53 | 1 anni | |
Ian Clements | M | 55 | 1 anni | |
Dennis Podlesak | M | 66 | 1 anni | |
Laurent Fischer | M | 60 | 1 anni | |
Theodore Schroeder | M | 69 | 5 anni | |
Tom Edward Pike | M | 64 | 6 anni | |
Pierre Legault | M | 63 | 2 anni | |
Itzhak Krinsky | M | 71 | 2 anni | |
Mahendra Shah | M | 79 | 1 anni | |
Asaf Yosef Frumerman | M | 39 | 2 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 82 | 82.00% |
Norvegia | 10 | 10.00% |
Israele | 8 | 8.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Gwen Melincoff
- Contatti personali